TMCI250117P7500
- 0.05
- 0.000.00%
Treace Medical Concepts Newsroom
A Piece Of The Puzzle Missing From Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) 26% Share Price Climb
Why Versus Systems Shares Are Trading Higher By Around 71%; Here Are 20 Stocks Moving Premarket
Truist Financial Maintains Treace Medical Concepts(TMCI.US) With Hold Rating
Stifel Maintains Treace Medical Concepts(TMCI.US) With Hold Rating
Analysts Have Conflicting Sentiments on These Healthcare Companies: Travere Therapeutics (TVTX), Treace Medical Concepts (TMCI) and X4 Pharmaceuticals (XFOR)
Treace Medical Concepts (TMCI) Receives a Hold From Stifel Nicolaus
Lake Street Maintains Treace Medical Concepts(TMCI.US) With Buy Rating, Maintains Target Price $14.5
Treace Medical Concepts Announces Preliminary Q4 Revenue Of $68.4M-$68.8M, Up 10% YoY; FY24 Revenue Of $209M-$209.4M, Up 12%; Added 280 Surgeons, Now 3,135 Active; Plans Innovative Product Launches In 2025
Treace Medical Concepts: Ended 2024 With About 3,135 Active Surgeons, Up 10% >TMCI
Express News | Treace Medical Concepts Inc Qtrly Preliminary Rev of $68.4 Million to $68.8 Million
Express News | Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2024 Revenue
Press Release: Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2024 Revenue
TMCI Stock May Gain From the Limited Release of the Percuplasty System
Treace to Present at 43rd Annual J.P. Morgan Healthcare Conference
Sector Update: Health Care Stocks Mixed Late Afternoon
This Vertex Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Tuesday
Lake Street Initiates Treace Medical Concepts(TMCI.US) With Buy Rating, Announces Target Price $14.5
Treace Expands Reach Into High-Volume Osteotomy Market With Second MIS Osteotomy Platform, Percuplasty Percutaneous 3D Bunion Correction Procedure
With 54% Institutional Ownership, Treace Medical Concepts, Inc. (NASDAQ:TMCI) Is a Favorite Amongst the Big Guns
Is Treace Medical Concepts (NASDAQ:TMCI) Weighed On By Its Debt Load?